Working… Menu

A Safety and Efficacy Study of Cryopreserved OTL-200 for Treatment of Metachromatic Leukodystrophy (MLD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03392987
Recruitment Status : Active, not recruiting
First Posted : January 8, 2018
Last Update Posted : October 6, 2021
Ospedale San Raffaele
Information provided by (Responsible Party):
Orchard Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 22, 2022
Estimated Study Completion Date : August 23, 2028